Recent studies highlight a dominant IFN-γ/IL-18 signature in mycobacterial HLH, sometimes with underlying genetic variants in HLH-related genes (e.g., PRF1, UNC13D) that lower the disease threshold (15, 16). This evidence concerns the gene PRF1 and hemophagocytic syndrome.